Trials / Not Yet Recruiting
Not Yet RecruitingNCT05886088
Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus
National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase III Clinical Trial to Evaluate the Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus
- Status
- Not Yet Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 597 (estimated)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of LID104 in the treatment of type 2 diabetes mellitus.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LID104 | Experimental |
| DRUG | Dapagliflozin | Active comparator |
| DRUG | Linagliptin | Active comparator |
Timeline
- Start date
- 2024-02-01
- Primary completion
- 2026-05-01
- Completion
- 2027-01-01
- First posted
- 2023-06-02
- Last updated
- 2023-06-02
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT05886088. Inclusion in this directory is not an endorsement.